Island Pharmaceuticals doses second cohort of subjects in ISLA-101 Single Ascending Dose study
Island Pharmaceuticals Ltd (ASX:ILA) has now dosed all eight subjects in the second cohort of its ISLA-101 Single Ascending Dose (SAD) study. ISLA-101 is a...